Skip to Main Content

Hepatitis A - vaccine

Definition:
Hepatitis is inflammation of the liver. The hepatitis A vaccine protects you against one type of hepatitis, hepatitis A. The vaccine stimulates your body to produce antibodies against the hepatitis A virus. Note that this vaccine will not protect you from other types of hepatitis. See also immunizations - general overview.



Alternative Names:
Vaccine - Hepatitis A; Immunization - Hepatitis A



Information:

The vaccine, called Havrix or VAQTA, is made from inactivated whole virus of hepatitis A. It is given by an injection in your arm. You should be protected against the disease within two weeks after receiving the first injection.

To ensure complete immunization against the disease, two vaccinations are required. After receiving the first vaccination, children and adults should have a booster vaccination in six to 12 months.

There is also a vaccine for adults called Twinrix that contains both Hepatitis A and B in combination. It reduces the number of needle sticks to achieve immunity to both viruses. It is given in 3 doses.

WHO SHOULD BE IMMUNIZED

People who work or travel in areas with high rates of infection should be vaccinated. These areas include Africa, Asia (except Japan), the Mediterranean, Eastern Europe, the Middle East, Central and Southern America, Mexico, and parts of the Caribbean. See the Centers for Disease Control and Prevention website for specific travel destination information.

If you are traveling to these areas before you are fully immunized (less than 4 weeks after first immunization), you should receive a prophylactic does of immunoglobulin (IG). If you are just a short-term traveler to these areas, you may wish to only receive the immunoglobulin (IG) instead of the vaccine.

This vaccine is mandated in children in Alaska, Arizona, Missouri, Nevada, New Mexico, Oklahoma, Tennessee, Texas, and Utah. In addition, the ACIP recommends vaccination in children in California, Montana, Idaho, Oregon, and Washington. These recommendations are based on the indidence of Hepatitis in these states.

Other people who are at higher risk for hepatitis A include:
  • Illicit intravenous drug users
  • People who work with the hepatitis A virus in a laboratory or with primates that may be infected with the virus
  • People who have chronic liver disease
  • People who receive clotting factor concentrate to treat hemophilia or other clotting disorders.
  • Military personnel
  • Homosexual or bisexual men
  • Employees of child day-care centers
  • People who care for institutionalized patients
WHO SHOULD NOT BE IMMUNIZED
  • People who have had hepatitis A in the past. Once you have recovered from the disease, you are immune for life.
  • People who are allergic to the components of the vaccine.
  • Children less than 2 years old.
  • Pregnant or nursing mothers.
  • If you are sick or have a fever, you should delay receiving the vaccine until you are feeling better.

RISKS

The possible complications are mild and rarely last longer than a day. The most common side effect of the vaccine is pain at the injection site. Other rare, but possible, side effects include:

  • Redness, swelling, or bruising at the injection site
  • Headache
  • Fever
  • Fatigue
  • Muscle aches
  • Nausea
  • Loss of appetite
CALL YOUR PRIMARY HEALTH CARE PROVIDER IF
  • You develop rash, itching, hives, or difficulty breathing after the injection.
  • You develop any other symptoms after hepatitis A immunization.
  • You have other questions or concerns about hepatitis A immunization.




Review Date: 12/1/2003

Reviewed By: D. Scott Smith, MD, MSc, DTM&H, Infectious Diseases Division and Dept. of Microbiology and Immunology, Stanford University Medical School, Stanford, CA. Review provided by VeriMed Healthcare Network.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).


The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2003 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.



HealthDay News

New Drug-Coated Stent Approved

SIDS Linked to Brain Chemical Dysfunction

Lots of Sex May Prevent Erectile Dysfunction

Health Highlights: July 3, 2008

HealthDay is a national consumer news and information company and the information it provides may not be consistent with the teachings of the Catholic Church. Avera Health, a ministry of the Catholic Church, does not recommend, endorse or offer procedures or interventions that are contrary to those teachings.

Your Personal Health Record

Access to your personal health information is critical to ensuring you receive timely, safe, and effective treatment and care. Learn more at MyPHR.com, a public resource designed to help you understand your personal health information.